Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 2 minute read Pharma Industry News Insmed enrolls adults in brensocatib phase 3 trial in bronchiectasis Insmed Incorporated said that it has wrapped up enrollment of adult patients in the ASPEN phase 3 clinical… byPallavi MadhirajuApril 2, 2023